CME Group Inc. (NASDAQ:CME) Director Daniel R. Glickman sold 850 shares of CME Group stock in a transaction that occurred on Monday, August 28th. The shares were sold at an average price of $126.65, for a total transaction of $107,652.50. Following the transaction, the director now directly owns 13,799 shares in the company, valued at approximately $1,747,643.35. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

CME Group Inc. (NASDAQ CME) opened at 126.06 on Thursday. The stock has a market cap of $42.85 billion, a P/E ratio of 25.73 and a beta of 0.73. The stock has a 50 day moving average of $123.67 and a 200 day moving average of $121.36. CME Group Inc. has a 12-month low of $98.95 and a 12-month high of $127.96.

CME Group (NASDAQ:CME) last posted its earnings results on Tuesday, August 1st. The financial services provider reported $1.23 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.20 by $0.03. The company had revenue of $925 million for the quarter, compared to analyst estimates of $931.05 million. CME Group had a return on equity of 7.61% and a net margin of 46.05%. CME Group’s revenue was up 2.1% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.14 earnings per share. On average, equities research analysts anticipate that CME Group Inc. will post $4.80 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Monday, September 25th. Shareholders of record on Friday, September 8th will be issued a $0.66 dividend. This represents a $2.64 annualized dividend and a yield of 2.09%. The ex-dividend date of this dividend is Thursday, September 7th. CME Group’s dividend payout ratio (DPR) is 53.99%.

COPYRIGHT VIOLATION NOTICE: “Daniel R. Glickman Sells 850 Shares of CME Group Inc. (CME) Stock” was posted by Watch List News and is the sole property of of Watch List News. If you are accessing this story on another publication, it was illegally copied and reposted in violation of U.S. and international copyright and trademark legislation. The legal version of this story can be read at https://www.watchlistnews.com/daniel-r-glickman-sells-850-shares-of-cme-group-inc-cme-stock/1533583.html.

CME has been the topic of several analyst reports. Deutsche Bank AG reaffirmed a “buy” rating and set a $133.00 price target (down previously from $134.00) on shares of CME Group in a report on Monday, May 15th. Jefferies Group LLC reaffirmed a “buy” rating and set a $134.00 price target (up previously from $128.00) on shares of CME Group in a report on Monday, July 17th. Royal Bank Of Canada set a $130.00 price target on shares of CME Group and gave the company a “buy” rating in a report on Monday, June 12th. BidaskClub raised shares of CME Group from a “sell” rating to a “hold” rating in a report on Thursday, August 3rd. Finally, Citigroup Inc. initiated coverage on shares of CME Group in a report on Wednesday, July 12th. They set a “buy” rating and a $140.00 price target on the stock. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and six have issued a buy rating to the company’s stock. CME Group has a consensus rating of “Buy” and an average target price of $131.63.

A number of hedge funds have recently bought and sold shares of the stock. Guardian Life Insurance Co. of America raised its stake in CME Group by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 1,309 shares of the financial services provider’s stock valued at $156,000 after buying an additional 9 shares during the period. Honkamp Krueger Financial Services Inc. raised its stake in CME Group by 0.4% in the second quarter. Honkamp Krueger Financial Services Inc. now owns 2,937 shares of the financial services provider’s stock valued at $368,000 after buying an additional 13 shares during the period. Pitcairn Co. raised its stake in CME Group by 0.4% in the first quarter. Pitcairn Co. now owns 3,247 shares of the financial services provider’s stock valued at $386,000 after buying an additional 14 shares during the period. Buffington Mohr McNeal raised its stake in CME Group by 0.3% in the first quarter. Buffington Mohr McNeal now owns 4,795 shares of the financial services provider’s stock valued at $570,000 after buying an additional 15 shares during the period. Finally, Summit Asset Management LLC raised its stake in CME Group by 0.5% in the first quarter. Summit Asset Management LLC now owns 3,016 shares of the financial services provider’s stock valued at $358,000 after buying an additional 16 shares during the period. 82.66% of the stock is currently owned by institutional investors.

CME Group Company Profile

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Insider Buying and Selling by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.